Remove 12 09 Current-FDA-COVID-19-developments
article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

Considerations for a Decentralized Manufacturing Paradigm Trudy Patterson Mon, 09/11/2023 - 06:47 Features September / October 2023 Considerations for a Decentralized Manufacturing Paradigm Marquerita Algorri, PhD Ting Wang, PhD Jocelyn X. McQueen Nina S.

article thumbnail

CMC Requirements for New Drug Registration in Latin America

ISPE

CMC Requirements for New Drug Registration in Latin America Trudy Patterson Tue, 05/09/2023 - 11:23 Features May / June 2023 CMC Requirements for New Drug Registration in Latin America Aicha Otmani Flavia C. Regulatory agencies can learn from the transformative experience required by COVID-19 pandemic restrictions.

article thumbnail

Enabling Global Pharma Innovation: Delivering for Patients

ISPE

This ISPE team developed a comprehensive survey, with the objective of gathering data on the specific origins, extent, and magnitude of the challenges and barriers that limit or reduce the development and implementation of innovative technologies. The survey launched in April 2023 and is still open !

FDA 52